Raynard E Washington1, Trevor J Orchard2, Vincent C Arena3, Ronald E LaPorte2, Aaron M Secrest2, Eugene S Tull2. 1. Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, United States. Electronic address: raynardewashington@gmail.com. 2. Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, United States. 3. Department of Biostatistics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, United States.
Abstract
OBJECTIVE: Type 1 diabetes remains a significant source of premature mortality; however, its burden has not been assessed in the U.S. Virgin Islands (USVI). As such, the objective of this study was to estimate type 1 diabetes mortality in a population-based registry sample in the USVI. RESEARCH DESIGN AND METHODS: We report overall and 20-year mortality in the USVI Childhood (<19 years old) Diabetes Registry Cohort diagnosed 1979-2005. Recent data for non-Hispanic blacks from the Allegheny County, PA population-based type 1 diabetes registry were used to compare mortality in the USVI to the contiguous U.S. RESULTS: As of December 31, 2010, the vital status of 94 of 103 total cases was confirmed (91.3%) with mean diabetes duration 16.8 ± 7.0 years. No deaths were observed in the 2000-2005 cohort. The overall mortality rates for those diagnosed 1979-1989 and 1990-1999 were 1852 and 782 per 100,000 person-years, respectively. Overall cumulative survival for USVI was 98% (95% CI: 97-99) at 10 years, 92% (95% CI: 89-95) at 15 years and 73% (95% CI: 66-80) at 20 years. The overall SMR for non-Hispanic blacks in the USVI was 5.8 (95% CI: 2.7-8.8). Overall mortality and cumulative survival for non-Hispanic blacks did not differ between the USVI and Allegheny County, PA. CONCLUSIONS: This study, as the first type 1 diabetes mortality follow-up in the USVI, confirmed previous findings of poor disease outcomes in racial/ethnic minorities with type 1 diabetes.
OBJECTIVE:Type 1 diabetes remains a significant source of premature mortality; however, its burden has not been assessed in the U.S. Virgin Islands (USVI). As such, the objective of this study was to estimate type 1 diabetes mortality in a population-based registry sample in the USVI. RESEARCH DESIGN AND METHODS: We report overall and 20-year mortality in the USVI Childhood (<19 years old) Diabetes Registry Cohort diagnosed 1979-2005. Recent data for non-Hispanic blacks from the Allegheny County, PA population-based type 1 diabetes registry were used to compare mortality in the USVI to the contiguous U.S. RESULTS: As of December 31, 2010, the vital status of 94 of 103 total cases was confirmed (91.3%) with mean diabetes duration 16.8 ± 7.0 years. No deaths were observed in the 2000-2005 cohort. The overall mortality rates for those diagnosed 1979-1989 and 1990-1999 were 1852 and 782 per 100,000 person-years, respectively. Overall cumulative survival for USVI was 98% (95% CI: 97-99) at 10 years, 92% (95% CI: 89-95) at 15 years and 73% (95% CI: 66-80) at 20 years. The overall SMR for non-Hispanic blacks in the USVI was 5.8 (95% CI: 2.7-8.8). Overall mortality and cumulative survival for non-Hispanic blacks did not differ between the USVI and Allegheny County, PA. CONCLUSIONS: This study, as the first type 1 diabetes mortality follow-up in the USVI, confirmed previous findings of poor disease outcomes in racial/ethnic minorities with type 1 diabetes.
Authors: William C Knowler; Elizabeth Barrett-Connor; Sarah E Fowler; Richard F Hamman; John M Lachin; Elizabeth A Walker; David M Nathan Journal: N Engl J Med Date: 2002-02-07 Impact factor: 91.245
Authors: J S Dorman; R E Laporte; L H Kuller; K J Cruickshanks; T J Orchard; D K Wagener; D J Becker; D E Cavender; A L Drash Journal: Diabetes Date: 1984-03 Impact factor: 9.461
Authors: J N Kostraba; J S Dorman; R E LaPorte; L H Kuller; T J Orchard; D J Becker; A L Drash Journal: Am J Epidemiol Date: 1991-01 Impact factor: 4.897
Authors: R E LaPorte; H A Fishbein; A L Drash; L H Kuller; B B Schneider; T J Orchard; D K Wagener Journal: Diabetes Date: 1981-04 Impact factor: 9.461
Authors: Jean M Lawrence; Kristi Reynolds; Sharon H Saydah; Amy Mottl; Catherine Pihoker; Dana Dabelea; Lawrence Dolan; Leora Henkin; Angela D Liese; Scott Isom; Jasmin Divers; Lynne Wagenknecht Journal: Diabetes Care Date: 2021-10-04 Impact factor: 19.112
Authors: Kristi Reynolds; Sharon H Saydah; Scott Isom; Jasmin Divers; Jean M Lawrence; Dana Dabelea; Elizabeth J Mayer-Davis; Giuseppina Imperatore; Ronny A Bell; Richard F Hamman Journal: J Diabetes Complications Date: 2018-04-04 Impact factor: 3.219